XML 48 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Equity Method Investments (Tables)
 12 Months Ended
Dec. 31, 2016
Equity Method Investments and Joint Ventures [Abstract]  
Condensed Financial Information of Equity Method Investment
Condensed financial information of the Company’s equity method investment in ICP is shown below:
 
Year Ended December 31,
ICP’s Operating results:
2016
 
2015
 
2014
Net sales(a)
$
177,401

 
$
166,905

 
$
236,486

Cost of sales and expenses(b)
(163,837
)
 
(146,098
)
 
(196,551
)
Net income
$
13,564

 
$
20,807

(c) 
$
39,935


(a) 
Includes related party sales to MGPI of $27,675, $38,941, and $36,289 for 2016, 2015, and 2014, respectively.
(b) 
Includes depreciation and amortization of $3,030, $2,634, and $2,847 for 2016, 2015, and 2014, respectively.
(c) 
Includes business interruption insurance proceeds of $4,112 for 2015.
The Company's Equity in Earnings (Loss) of Joint Ventures
The Company’s equity method investment earnings (losses) are as follows:
 
 
Year Ended December 31,
 
2016
 
2015
 
2014
ICP (30% interest)
$
4,069

 
$
6,242

 
$
10,098

DMI (50% interest)
(33
)
(a) 
(140
)
 
39

  Total
$
4,036

 
$
6,102

 
$
10,137



(a) 
On December 23, 2016, the Company received its portion of the remaining DMI liquidation proceeds totaling $351. Prior to receiving the proceeds, the Company's equity method investment was $384. The difference of $33 was recognized as an equity method investment loss for the year ended December 31, 2016.
Schedule of Equity Method Investments
The Company’s equity method investments are as follows:
 
December 31,
 
2016
 
2015
ICP (30% interest) (a)
$
18,934

 
$
18,179

DMI (50% interest)
—

 
384

  Total
$
18,934

 
$
18,563


(a) 
During 2016, the Company received a $3,300 cash distribution from ICP, which reduced the Company's investment in ICP.